Patents by Inventor Benjamin Jay Feldman

Benjamin Jay Feldman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260157670
    Abstract: Provided are dermal sensors and dermal sensor applicator sets to insert at least a portion of a dermal sensor into a dermal layer of a subject, as well as methods of making and using the same.
    Type: Application
    Filed: June 12, 2025
    Publication date: June 11, 2026
    Inventors: Benjamin Jay Feldman, Hyun Cho, John Charles Mazza
  • Patent number: 12569166
    Abstract: Systems, devices and methods are provided for inserting at least a portion of an in vivo analyte sensor, such as a dermal sensor, for sensing an analyte level in a bodily fluid of a subject. An applicator is positioned against a skin surface and a force is applied to the applicator causing at least a portion of a sharp and an in vivo analyte sensor to be positioned in the body of the subject. In particular, disclosed herein are embodiments of applicators designed to prevent premature sharp withdrawal and/or reduce the likelihood of improper sensor insertion. Also disclosed are embodiments of applicators including sharp modules having an angled sharp which can be configured to create an insertion path for a sensor.
    Type: Grant
    Filed: February 8, 2022
    Date of Patent: March 10, 2026
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Vivek S. Rao, Louis G. Pace, Hyun Cho, Benjamin Jay Feldman, Yi Wang, Tuan Nguyen
  • Patent number: 12551105
    Abstract: Various embodiments of systems, devices and methods for improving the accuracy of an analyte sensor and for detecting sensor fault conditions are disclosed. According to some embodiments, these systems, devices, and methods can utilize a first data collected by a glucose sensor and a second data collected by a secondary sensing element. In some embodiments, the secondary sensing element can be one of a lactate sensing element, a ketone sensing element, or a heart rate monitor, among others.
    Type: Grant
    Filed: June 7, 2021
    Date of Patent: February 17, 2026
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Erwin S. Budiman, Yi Wang, Benjamin Jay Feldman, Hyun Cho, Kuan-Chou Chen, Lam N. Tran, Stephen Oja, Tianmei Ouyang
  • Patent number: 12495993
    Abstract: Systems, devices and methods are provided for inserting at least a portion of an in vivo analyte sensor, such as a dermal sensor, for sensing an analyte level in a bodily fluid of a subject. An applicator is positioned against a skin surface and a force is applied to the applicator causing at least a portion of a sharp and an in vivo analyte sensor to be positioned in the body of the subject. In particular, disclosed herein are embodiments of applicators designed to prevent premature sharp withdrawal and/or reduce the likelihood of improper sensor insertion. Also disclosed are embodiments of applicators including sharp modules having an angled sharp which can be configured to create an insertion path for a sensor.
    Type: Grant
    Filed: June 6, 2025
    Date of Patent: December 16, 2025
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Vivek S. Rao, Louis G. Pace, Hyun Cho, Benjamin Jay Feldman, Yi Wang, Tuan Nguyen
  • Patent number: 12482558
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user.
    Type: Grant
    Filed: December 2, 2019
    Date of Patent: November 25, 2025
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Publication number: 20250318754
    Abstract: Systems, devices and methods are provided for inserting at least a portion of an in vivo analyte sensor, such as a dermal sensor, for sensing an analyte level in a bodily fluid of a subject. An applicator is positioned against a skin surface and a force is applied to the applicator causing at least a portion of a sharp and an in vivo analyte sensor to be positioned in the body of the subject. In particular, disclosed herein are embodiments of applicators designed to prevent premature sharp withdrawal and/or reduce the likelihood of improper sensor insertion. Also disclosed are embodiments of applicators including sharp modules having an angled sharp which can be configured to create an insertion path for a sensor.
    Type: Application
    Filed: June 6, 2025
    Publication date: October 16, 2025
    Inventors: Vivek S. Rao, Louis G. Pace, Hyun Cho, Benjamin Jay Feldman, Yi Wang, Tuan Nguyen
  • Patent number: 12396666
    Abstract: Provided are sensors and sensor applicator sets to insert at least a portion of an analyte sensor into a a skin surface of a subject, as well as methods of using the same.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: August 26, 2025
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Benjamin Jay Feldman, Hyun Cho, John Charles Mazza
  • Patent number: 12326441
    Abstract: Techniques for data processing and control for a glucose monitoring system are provided, including obtaining a first sensitivity of a glucose sensor; obtaining a second sensitivity of the glucose sensor; comparing a difference between the first sensitivity and the second sensitivity to a predetermined range of values; if the difference is outside the predetermined range of the values, causing a calibration routine for the glucose sensor to be performed; and if the difference is within the predetermined range of values determining a composite sensitivity for a current calibration of the glucose sensor based on the first sensitivity and the second sensitivity and calculating the glucose level based on the current calibration of the glucose sensor.
    Type: Grant
    Filed: October 24, 2023
    Date of Patent: June 10, 2025
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John Charles Mazza, Benjamin Jay Feldman
  • Publication number: 20250172539
    Abstract: Techniques for data processing and control for a glucose monitoring system are provided, including obtaining a first sensitivity of a glucose sensor; obtaining a second sensitivity of the glucose sensor; comparing a difference between the first sensitivity and the second sensitivity to a predetermined range of values; if the difference is outside the predetermined range of the values, causing a calibration routine for the glucose sensor to be performed; and if the difference is within the predetermined range of values determining a composite sensitivity for a current calibration of the glucose sensor based on the first sensitivity and the second sensitivity and calculating the glucose level based on the current calibration of the glucose sensor.
    Type: Application
    Filed: January 16, 2025
    Publication date: May 29, 2025
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John Charles Mazza, Benjamin Jay Feldman
  • Patent number: 12313622
    Abstract: Techniques for data processing and control for a glucose monitoring system are provided, including obtaining a first sensitivity of a glucose sensor; obtaining a second sensitivity of the glucose sensor; comparing a difference between the first sensitivity and the second sensitivity to a predetermined range of values; if the difference is outside the predetermined range of the values, causing a calibration routine for the glucose sensor to be performed; and if the difference is within the predetermined range of values determining a composite sensitivity for a current calibration of the glucose sensor based on the first sensitivity and the second sensitivity and calculating the glucose level based on the current calibration of the glucose sensor.
    Type: Grant
    Filed: April 11, 2022
    Date of Patent: May 27, 2025
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John Charles Mazza, Benjamin Jay Feldman
  • Patent number: 12268496
    Abstract: Systems, devices and methods are provided for inserting at least a portion of an in vivo analyte sensor, such as a dermal sensor, for sensing an analyte level in a bodily fluid of a subject. An applicator is positioned against a skin surface and a force is applied to the applicator causing at least a portion of a sharp and an in vivo analyte sensor to be positioned in the body of the subject. In particular, disclosed herein are embodiments of applicators designed to prevent premature sharp withdrawal and/or reduce the likelihood of improper sensor insertion. Also disclosed are embodiments of applicators including sharp modules having an angled sharp which can be configured to create an insertion path for a sensor.
    Type: Grant
    Filed: June 24, 2021
    Date of Patent: April 8, 2025
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Vivek S. Rao, Louis G. Pace, Hyun Cho, Benjamin Jay Feldman, Yi Wang, Tuan Nguyen
  • Publication number: 20250006363
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.
    Type: Application
    Filed: September 16, 2024
    Publication date: January 2, 2025
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Daniel Milfred Bernstein, MIchael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Louis George Pace, Jeffery Mario Sicurello
  • Publication number: 20240341639
    Abstract: Embodiments of the present disclosure include a method for receiving sensor data indicative of a glucose level from a glucose sensor configured to be positioned in contact with a bodily fluid under a skin surface of a subject, receiving, from a temperature sensor, temperature data indicative of a temperature of the skin surface, determining a rate of change of the glucose level, wherein the rate of change indicates a presence of a hypoglycemic condition, determining that a variation of the temperature of the skin surface is within a predetermined range of temperature values, and determining, in response to the variation of the temperature data, that the rate of change of the glucose level corresponds to a sensor signal attenuation.
    Type: Application
    Filed: June 27, 2024
    Publication date: October 17, 2024
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Benjamin Jay Feldman, Adam Heller, Namvar Kiaie
  • Patent number: 12048530
    Abstract: Embodiments of the present disclosure include detecting a concurrent occurrence of a decrease in monitored analyte level and a corresponding decrease in monitored on-skin temperature, confirming a presence of an impending hypoglycemic condition, and asserting a notification corresponding to the confirmed impending hypoglycemic condition. Devices, methods, systems and kits incorporating the same are also provided.
    Type: Grant
    Filed: December 27, 2021
    Date of Patent: July 30, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Benjamin Jay Feldman, Adam Heller, Namvar Kiaie
  • Publication number: 20240081700
    Abstract: Method and system for providing continuous calibration of analyte sensors includes calibrating a first sensor, receiving data associated with detected analyte levels from the first sensor, and calibrating a second sensor based on a predetermined scaling factor and data associated with detected analyte levels from the first sensor, is disclosed.
    Type: Application
    Filed: November 17, 2023
    Publication date: March 14, 2024
    Applicant: ABBOTT DIABETES CARE INC.
    Inventor: Benjamin Jay Feldman
  • Publication number: 20240069009
    Abstract: Techniques for data processing and control for a glucose monitoring system are provided, including obtaining a first sensitivity of a glucose sensor; obtaining a second sensitivity of the glucose sensor; comparing a difference between the first sensitivity and the second sensitivity to a predetermined range of values; if the difference is outside the predetermined range of the values, causing a calibration routine for the glucose sensor to be performed; and if the difference is within the predetermined range of values determining a composite sensitivity for a current calibration of the glucose sensor based on the first sensitivity and the second sensitivity and calculating the glucose level based on the current calibration of the glucose sensor.
    Type: Application
    Filed: October 24, 2023
    Publication date: February 29, 2024
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John Charles Mazza, Benjamin Jay Feldman
  • Patent number: 11872039
    Abstract: Method and system for providing continuous calibration of analyte sensors includes calibrating a first sensor, receiving data associated with detected analyte levels from the first sensor, and calibrating a second sensor based on a predetermined scaling factor and data associated with detected analyte levels from the first sensor, is disclosed.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: January 16, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventor: Benjamin Jay Feldman
  • Patent number: 11828748
    Abstract: Techniques for data processing and control for a glucose monitoring system are provided, including obtaining a first sensitivity of a glucose sensor; obtaining a second sensitivity of the glucose sensor; comparing a difference between the first sensitivity and the second sensitivity to a predetermined range of values; if the difference is outside the predetermined range of the values, causing a calibration routine for the glucose sensor to be performed; and if the difference is within the predetermined range of values determining a composite sensitivity for a current calibration of the glucose sensor based on the first sensitivity and the second sensitivity and calculating the glucose level based on the current calibration of the glucose sensor.
    Type: Grant
    Filed: May 3, 2022
    Date of Patent: November 28, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John Charles Mazza, Benjamin Jay Feldman
  • Publication number: 20230268071
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.
    Type: Application
    Filed: February 28, 2023
    Publication date: August 24, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Publication number: 20230238131
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.
    Type: Application
    Filed: April 3, 2023
    Publication date: July 27, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello